echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The average price reduction of anticancer drugs in Beijing is more than 9%

    The average price reduction of anticancer drugs in Beijing is more than 9%

    • Last Update: 2018-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the website of the Beijing municipal health and Family Planning Commission, according to the decision of the State Council to fight the procurement of cancer drugs, the payment standard and purchase price of 14 anticancer drugs were adjusted in two batches in September 1st and September 30th The first group had 8 price adjustment before September 1st, and the second group had 6 price adjustment before September 30th Beijing Municipal Commission of health and family planning said that in order to implement the national requirements and enable patients to enjoy the benefits of price adjustment as soon as possible, Beijing responded quickly and deployed carefully The municipal pharmaceutical sunshine procurement platform developed the function of active price reduction, encouraged enterprises to reduce prices as soon as possible, and reminded medical institutions to timely connect and change prices By 0:00 on September 1, the prices of the first eight drugs were all adjusted in place, and patients were synchronized Enjoy the results of price reduction According to the relevant person in charge of Beijing health and Family Planning Commission, the first batch of varieties involved in price adjustment included 8 varieties, including Zeke, Kemena, aitan, fenitor, refume, Herceptin, Troika and taliza, with an average decrease of 4.5% The person in charge stressed that in the next step, Beijing will implement the price adjustment of the second batch of varieties on schedule, and at the same time, start the special procurement of anticancer drugs at the provincial level to further realize the terminal price reduction effect on the basis of tax reduction The person in charge also pointed out that since the implementation of the comprehensive reform of the separation of medicine in Beijing on April 8 last year, under the sunshine purchase mechanism, the drug price has continued to decline, saving more than 8 billion yuan in overall drug costs, and the average drop in drug prices has exceeded 9%.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.